{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:31:31Z","timestamp":1782275491310,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) induces lung injury of varying severity, potentially causing severe acute respiratory distress syndrome (ARDS). Pulmonary injury patterns in COVID-19 patients differ from those in patients with other causes of ARDS. We aimed to explore the frequency and pathogenesis of cavitary lung lesions in critically ill patients with COVID-19. Retrospective study in 39 critically ill adult patients hospitalized with severe acute respiratory syndrome coronavirus 2 including lung injury of varying severity in a tertiary care referral center during March and May 2020, Berlin\/Germany. We observed lung cavitations in an unusually large proportion of 22\/39 (56%) COVID-19 patients treated on intensive care units (ICU), including 3\/5 patients without mechanical ventilation. Median interquartile range (IQR) time between onset of symptoms and ICU admission was 11.5 (6.25\u201317.75) days. In 15 patients, lung cavitations were already present on the first CT scan, performed after ICU admission; in seven patients they developed during a subsequent median (IQR) observation period of 48 (35\u201358) days. In seven patients we found at least one cavitation with a diameter\u2009&gt;\u20092\u00a0cm (maximum 10\u00a0cm). Patients who developed cavitations were older and had a higher body mass index. Autopsy findings in three patients revealed that the cavitations reflected lung infarcts undergoing liquefaction, secondary to thrombotic pulmonary artery branch occlusions. Lung cavitations appear to be a frequent complication of severely ill COVID-19 patients, probably related to the prothrombotic state associated with COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-021-95694-0","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T10:02:56Z","timestamp":1628244176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Jan Matthias","family":"Kruse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie M.","family":"L\u00fcdemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie K.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Gotthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Ihlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Greuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefer","family":"Elezkurtaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"issue":"4","key":"95694_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/v12040372","volume":"12","author":"Y Jin","year":"2020","unstructured":"Jin, Y. et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12(4), 372 (2020).","journal-title":"Viruses"},{"issue":"5","key":"95694_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20(5), 533\u2013534 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"10223","key":"95694_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223), 497\u2013506 (2020).","journal-title":"Lancet"},{"issue":"3","key":"95694_CR4","first-page":"200","volume":"22","author":"A Zangrillo","year":"2020","unstructured":"Zangrillo, A. et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit. Care Resusc. 22(3), 200\u2013211 (2020).","journal-title":"Crit. Care Resusc."},{"issue":"6","key":"95694_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","volume":"46","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni, L. et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes?. Intensive Care Med. 46(6), 1099\u20131102 (2020).","journal-title":"Intensive Care Med."},{"issue":"2","key":"95694_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N. Engl. J. Med. 383(2), 120\u2013128 (2020).","journal-title":"N. Engl. J. Med."},{"key":"95694_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 191, 148\u2013150 (2020).","journal-title":"Thromb Res."},{"key":"95694_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 191, 145\u2013147 (2020).","journal-title":"Thromb Res."},{"issue":"10234","key":"95694_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234), 1417\u20131418 (2020).","journal-title":"Lancet"},{"issue":"5","key":"95694_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/M20-2566","volume":"173","author":"SF Lax","year":"2020","unstructured":"Lax, S. F. et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann. Intern. Med. 173(5), 350\u2013361 (2020).","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"95694_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173(4), 268\u2013277 (2020).","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"95694_CR12","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S1473-3099(20)30367-4","volume":"20","author":"M Lang","year":"2020","unstructured":"Lang, M. et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis. 20(12), 1365\u20131366 (2020).","journal-title":"Lancet Infect Dis."},{"issue":"3","key":"95694_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell, D. M. et al. Fleischner society: glossary of terms tor thoracic imaging. Radiology 246(3), 697\u2013722 (2008).","journal-title":"Radiology"},{"issue":"3","key":"95694_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4103\/0971-9784.185546","volume":"19","author":"K Gorlinger","year":"2016","unstructured":"Gorlinger, K., Bhardwaj, V. & Kapoor, P. M. Simulation in coagulation testing using rotational thromboelastometry: a fast emerging, reliable point of care technique. Ann. Card Anaesth. 19(3), 516\u2013520 (2016).","journal-title":"Ann. Card Anaesth."},{"issue":"4","key":"95694_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 20(4), 425\u2013434 (2020).","journal-title":"Lancet Infect Dis."},{"key":"95694_CR16","doi-asserted-by":"publisher","first-page":"109009","DOI":"10.1016\/j.ejrad.2020.109009","volume":"127","author":"X Ding","year":"2020","unstructured":"Ding, X., Xu, J., Zhou, J. & Long, Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur. J. Radiol. 127, 109009 (2020).","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"95694_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5334\/jbr-btr.1202","volume":"100","author":"AP Parkar","year":"2016","unstructured":"Parkar, A. P. & Kandiah, P. Differential diagnosis of cavitary lung lesions. J. Belg. Soc. Radiol. 100(1), 100 (2016).","journal-title":"J. Belg. Soc. Radiol."},{"issue":"3","key":"95694_CR18","first-page":"11","volume":"2","author":"H Harris","year":"2008","unstructured":"Harris, H. et al. Cavitating lung lesions in chronic thromboembolic pulmonary hypertension. J. Radiol. Case Rep. 2(3), 11\u201321 (2008).","journal-title":"J. Radiol. Case Rep."},{"key":"95694_CR19","doi-asserted-by":"publisher","first-page":"e1373","DOI":"10.6061\/clinics\/2020\/e1373","volume":"75","author":"C Fernandes","year":"2020","unstructured":"Fernandes, C. et al. Lung cavities in chronic thromboembolic pulmonary hypertension. Clinics (Sao Paulo). 75, e1373 (2020).","journal-title":"Clinics (Sao Paulo)."},{"issue":"3","key":"95694_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/157016106777698432","volume":"4","author":"AI Kakafika","year":"2006","unstructured":"Kakafika, A. I., Liberopoulos, E. N., Karagiannis, A., Athyros, V. G. & Mikhailidis, D. P. Dyslipidaemia, hypercoagulability and the metabolic syndrome. Curr. Vasc. Pharmacol. 4(3), 175\u2013183 (2006).","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"1\u20133","key":"95694_CR21","first-page":"35","volume":"22","author":"X Mao","year":"2012","unstructured":"Mao, X., Ait-Aissa, K., Lagrange, J., Youcef, G. & Louis, H. Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease. Biomed. Mater. Eng. 22(1\u20133), 35\u201348 (2012).","journal-title":"Biomed. Mater. Eng."},{"issue":"4","key":"95694_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1365-2796.2003.01288.x","volume":"255","author":"A Mavri","year":"2004","unstructured":"Mavri, A., Alessi, M. C. & Juhan-Vague, I. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases. J. Intern. Med. 255(4), 448\u2013456 (2004).","journal-title":"J. Intern. Med."},{"issue":"2","key":"95694_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.coph.2004.10.003","volume":"5","author":"M Nieuwdorp","year":"2005","unstructured":"Nieuwdorp, M., Stroes, E. S., Meijers, J. C. & Buller, H. Hypercoagulability in the metabolic syndrome. Curr. Opin. Pharmacol. 5(2), 155\u2013159 (2005).","journal-title":"Curr. Opin. Pharmacol."},{"issue":"Suppl 1","key":"95694_CR24","first-page":"S11","volume":"19","author":"P Vague","year":"1995","unstructured":"Vague, P., Raccah, D. & Scelles, V. Hypofibrinolysis and the insulin resistance syndrome. Int. J. Obes. Relat. Metab. Disord. 19(Suppl 1), S11\u2013S15 (1995).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"17","key":"95694_CR25","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan, M. et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 382(17), 1653\u20131659 (2020).","journal-title":"N Engl J Med."},{"issue":"5","key":"95694_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/micc.12120","volume":"21","author":"EY Senchenkova","year":"2014","unstructured":"Senchenkova, E. Y., Russell, J., Esmon, C. T. & Granger, D. N. Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis. Microcirculation 21(5), 401\u2013407 (2014).","journal-title":"Microcirculation"},{"issue":"10","key":"95694_CR27","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","volume":"201","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni, L. et al. COVID-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 201(10), 1299\u20131300 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"95694_CR28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1164\/rccm.201507-1508LE","volume":"193","author":"C Galambos","year":"2016","unstructured":"Galambos, C., Sims-Lucas, S., Abman, S. H. & Cool, C. D. Intrapulmonary bronchopulmonary anastomoses and plexiform lesions in idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit Care Med. 193(5), 574\u2013576 (2016).","journal-title":"Am. J. Respir. Crit Care Med."},{"issue":"7","key":"95694_CR29","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/jth.14828","volume":"18","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J. Thromb. Haemost. 18(7), 1752\u20131755 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"95694_CR30","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18(6), 1421\u20131424 (2020).","journal-title":"J. Thromb. Haemost."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95694-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:14:31Z","timestamp":1670069671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95694"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95694-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16039"}}